![[Toyota Times] From Strengthening Foundations to Boosting Productivity - Toyota Focuses on Break-Even Volume](https://businessfortnight.com/wp-content/uploads/2025/11/Toyota-Times-From-Strengthening-Foundations-to-Boosting-Productivity-Toyota-218x150.jpg "[Toyota Times] From Strengthening Foundations to Boosting Productivity – Toyota Focuses on Break-Even Volume")
EDMONTON, Alberta, Oct. 21, 2022 (GLOBE NEWSWIRE) — Canadian healthcare professionals who assist sufferers residing with weight problems now have up-to-date data on the most recent proof for 2 essential weight problems remedy paradigms: medical diet remedy (MNT) and pharmacotherapy.
Obesity Canada and the Canadian Association of Bariatric Physicians and Surgeons launched the Canadian Adult Obesity Clinical Practice Guidelines (CPGs) in 2020 after an exhaustive two-year evaluation of greater than 500,000 peer reviewed papers. A abstract of 80 medical suggestions was revealed within the Canadian Medical Association Journal in August of 2020, changing into the journal’s top-read paper within the first yr of the COVID-19 pandemic. Nineteen supplementary chapters that go into nice element on a variety of weight problems prevention and remedy points had been concurrently revealed at www.obesitycanada.ca/pointers.
The core pillars of weight problems administration within the CPGs embrace psychological/behavioural interventions, drugs and bariatric surgical procedure, for which medical diet remedy and bodily exercise act as adjunctive therapies. The CPGs had been created as a residing information repository, to be up to date when important new analysis is revealed.
“The literature search and evidence synthesis for the guidelines was a labour-intensive and time-consuming task, and so our original date range for assessing peer-reviewed papers was January 2006 to June 2018,” says Dr. Mary Forhan, Scientific Director for Obesity Canada and Associate Professor and Chair of the Department of Occupational Science and Occupational Therapy on the University of Toronto. “There is heightened interest in obesity research today, and we felt that there were enough new publications in pharmacotherapy – coinciding with the approval of a fourth obesity medication in Canada – and medical nutrition therapy to warrant updates to these chapters.”
Dr. Forhan added that MNT chapter authors up to date a literature overview between November 2018 and March 2021 to decide if any important proof has emerged that will assist medical follow. Two areas had been recognized as offering up to date proof presently within the MNT chapter suggestions: i) use of partial meal replacements; and ii) intermittent fasting. Neither space supplied sufficient proof to change the present suggestions, however an up to date listing of references is on the market for readers of the chapter.
The medicine chapter up to date suggestions to embrace the fourth medicine now authorised for weight problems administration in Canada, semaglutide 2.4mg. There are new suggestions on using pharmacotherapy together with health-behaviour modifications to i) deal with individuals with obstructive sleep apnea and BMI ≥ 30 kg/m2 for weight reduction and related enchancment in apnea-hypopnea index and ii) deal with individuals residing with non-alcoholic steatohepatitis (NASH) and chubby or weight problems for weight reduction and enchancment of NASH parameters. A 3rd new advice means that metformin and psychological remedy (corresponding to cognitive behavioural remedy) ought to be thought of for prevention of weight achieve in individuals with extreme psychological sickness who’re handled with antipsychotic drugs related to weight achieve. New sections embrace the impact of weight problems drugs on cravings and high quality of life, two elements of weight problems care which are essential for a lot of sufferers. The chapter additionally discusses the position of rising drugs corresponding to tirzepatide and setmelanotide.
The methodologies for updating every chapter are on the CPG website.
“Updates to the CPGs are important to ensure Obesity Canada is providing the most up-to-date evidence for healthcare providers and patients to make shared decisions,” Dr. Forhan added. “We will continue to revisit each recommendation when new research suggests a change to our recommendations is warranted.”
More data or to prepare interviews: Nicole Pearce, Obesity Canada, [email protected] / +1-780-492-8361
About Obesity Canada
Obesity Canada-Obésité Canada is Canada’s authoritative voice on evidence-based approaches for weight problems prevention, remedy, and coverage. Our mission is to enhance the lives of Canadians affected by weight problems by way of the development of anti-discrimination, prevention, and remedy efforts. www.obesitycanada.ca
